D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
Wintergreen Acquisition Corp
WTG
$78.1M
| $1.03M | ﹤0.01% |
100,000
| – | – |
2025 Q3
2 quarters
|
|
3327
JBG SMITH
JBGS
$656M
| $1.02M | ﹤0.01% |
70,110
-37,145
| -35% | -$592K |
2023 Q3
10 quarters
|
|
3328
International Money Express
IMXI
$328M
| $1.02M | ﹤0.01% |
64,526
-32,938
| -34% | -$515K |
2025 Q2
3 quarters
|
|
3329
Alto Neuroscience
ANRO
$868M
| $1.02M | ﹤0.01% |
45,343
-79,452
| -64% | -$1.47M |
2025 Q4
1 quarter
|
|
3330
CALL
Enlight Renewable Energy
ENLT
$9.98B
| $1.02M | ﹤0.01% |
+14,900
| New | +$953K |
2026 Q1
0 quarters
|
|
3331
PUT
Dycom Industries
DY
$7.8B
| $1.02M | ﹤0.01% |
3,000
+1,400
| +88% | +$526K |
2025 Q4
1 quarter
|
|
3332
Emcor
EME
$32.3B
| $1.02M | ﹤0.01% |
1,376
-1,141
| -45% | -$830K |
2022 Q1
16 quarters
|
|
3333
Stitch Fix
SFIX
$350M
| $1.02M | ﹤0.01% |
306,828
-75,633
| -20% | -$309K |
2019 Q4
25 quarters
|
|
3334
Tompkins Financial
TMP
$1.41B
| $1.02M | ﹤0.01% |
12,875
-3,381
| -21% | -$263K |
2024 Q1
8 quarters
|
|
3335
CALL
DocuSign
DOCU
$14.3B
| $1.01M | ﹤0.01% |
21,400
-36,200
| -63% | -$1.85M |
2019 Q4
25 quarters
|
|
3336
DELISTED
Soleno Therapeutics
SLNO
| $1.01M | ﹤0.01% |
30,247
+24,480
| +424% | +$960K |
2025 Q1
4 quarters
|
|
3337
Cantor Equity Partners VI
CEPS
$148M
| $1.01M | ﹤0.01% |
+100,000
| New | +$1.01M |
2026 Q1
0 quarters
|
|
3338
AudioCodes
AUDC
$276M
| $1.01M | ﹤0.01% |
120,291
-3,720
| -3% | -$30.2K |
2023 Q1
12 quarters
|
|
3339
NioCorp Developments
NB
$486M
| $1.01M | ﹤0.01% |
226,516
+93,294
| +70% | +$535K |
2025 Q3
2 quarters
|
|
3340
Cantor Equity Partners V
CEPV
$324M
| $1.01M | ﹤0.01% |
100,000
| – | – |
2025 Q4
1 quarter
|
|
3341
Lincoln Electric
LECO
$14.4B
| $1.01M | ﹤0.01% |
4,054
-956
| -19% | -$256K |
2022 Q2
15 quarters
|
|
3342
State Street Energy Select Sector SPDR ETF
XLE
$43.2B
| $1.01M | ﹤0.01% |
+16,440
| New | +$882K |
2026 Q1
0 quarters
|
|
3343
PUT
Grab
GRAB
$12.2B
| $1.01M | ﹤0.01% |
275,000
-180,000
| -40% | -$763K |
2025 Q3
2 quarters
|
|
3344
Winnebago Industries
WGO
$707M
| $1.01M | ﹤0.01% |
32,462
-113,307
| -78% | -$4.72M |
2021 Q3
18 quarters
|
|
3345
AGNT Inc
AGNT
$673M
| $1M | ﹤0.01% |
167,673
-107,078
| -39% | -$828K |
2025 Q1
4 quarters
|
|
3346
Smith Douglas Homes
SDHC
$89.1M
| $1M | ﹤0.01% |
78,426
+45,176
| +136% | +$742K |
2024 Q1
8 quarters
|
|
3347
DELISTED
Catalyst Pharmaceutical
CPRX
| $1M | ﹤0.01% |
40,542
+29,762
| +276% | +$709K |
2024 Q4
5 quarters
|
|
3348
CALL
KeyCorp
KEY
$21.5B
| $1M | ﹤0.01% |
50,000
-277,500
| -85% | -$5.81M |
2025 Q3
2 quarters
|
|
3349
Invest Green Acquisition Corp
IGAC
$241M
| $1M | ﹤0.01% |
+100,797
| New | +$1,000K |
2026 Q1
0 quarters
|
|
3350
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.1B
| $1M | ﹤0.01% |
25,404
-83,829
| -77% | -$3.4M |
2025 Q4
1 quarter
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.